We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
26
UnitedHealth
UNH
$382B
$80.8M 0.83%
366,300
– –
SPGI icon
27
S&P Global
SPGI
$126B
$80M 0.83%
472,180
+13,660
+3% +$2.23M
WFC icon
28
Wells Fargo
WFC
$261B
$70.8M 0.73%
1,166,462
+24,926
+2% +$1.41M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$67.7M 0.7%
566,371
+33,371
+6% +$4.06M
PFE icon
30
Pfizer
PFE
$140B
$66.1M 0.68%
1,922,153
-99,358
-5% -$3.39M
ALNY icon
31
Alnylam Pharmaceuticals
ALNY
$36.3B
$65.6M 0.68%
+516,232
New +$64.9M
RTX icon
32
RTX Corp
RTX
$287B
$65.4M 0.68%
815,081
+49,154
+6% +$3.73M
AMD icon
33
Advanced Micro Devices
AMD
$851B
$65.4M 0.68%
6,362,792
+2,024,917
+47% +$23.7M
SAVE
34
DELISTED
Spirit Airlines, Inc.
SAVE
$65.4M 0.67%
1,457,536
+822,594
+130% +$31.6M
AMD icon
35
CALL
Advanced Micro Devices
AMD
$851B
$64.1M 0.66%
6,240,000
+2,550,000
+69% +$29.8M
Y
36
DELISTED
Alleghany Corp
Y
$63.5M 0.65%
106,450
+21,450
+25% +$12.2M
WRB icon
37
W.R. Berkley
WRB
$28B
$63.1M 0.65%
2,973,375
+450,562
+18% +$9.21M
NKTR icon
38
Nektar Therapeutics
NKTR
$2.39B
$60.8M 0.63%
+67,852
New +$40.1M
HUM icon
39
Humana
HUM
$46.7B
$59.6M 0.62%
240,436
+45,000
+23% +$11.1M
MHK icon
40
Mohawk Industries
MHK
$6.9B
$58.7M 0.61%
212,724
-409
-0.2% -$110K
SU icon
41
Suncor Energy
SU
$77.7B
$58.2M 0.6%
1,414,809
-192,067
-12% -$6.67M
SYK icon
42
Stryker
SYK
$127B
$57.2M 0.59%
+369,200
New +$56.3M
BIO icon
43
Bio-Rad Laboratories Class A
BIO
$8.42B
$55.6M 0.57%
233,000
+97,805
+72% +$23.7M
KEX icon
44
Kirby Corp
KEX
$7.95B
$54.9M 0.57%
822,512
+39,120
+5% +$2.56M
PRAH
45
DELISTED
PRA Health Sciences, Inc.
PRAH
$54.6M 0.56%
+599,294
New +$49.9M
ACN icon
46
Accenture
ACN
$89.9B
$54.2M 0.56%
354,045
+20,682
+6% +$3M
ZEN
47
DELISTED
ZENDESK INC
ZEN
$54.1M 0.56%
1,599,480
-246,350
-13% -$8.06M
ESNT icon
48
Essent Group
ESNT
$6.06B
$53.8M 0.56%
1,239,000
+37,800
+3% +$1.65M
DOX icon
49
Amdocs
DOX
$5.53B
$53.6M 0.55%
819,257
-49,799
-6% -$3.23M
BRO icon
50
Brown & Brown
BRO
$22.9B
$51.4M 0.53%
1,998,862
+1,484,962
+289% +$37.3M
1
2
3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.